Lungpacer Medical
EXTON, Pennsylvania, United States · Healthcare, Health Care
Lungpacer Medical, Inc., is a privately held medical device company focused on improving respiratory and critical care medicine. Headquartered in Vancouver, Canada, and with US offices in Exton, Pennsylvania, Lungpacer Medical is dedicated to designing non-surgical, minimally invasive technologies to ventilate patients more safely and effectively.
Key facts
- Headquarters
- EXTON, Pennsylvania, United States
- Employees
- 58
- Industries
- Healthcare, Health Care
- Status
- Private
- Website
- lungpacer.com
- Company page
Recent activity at Lungpacer Medical
- : Lungpacer Medical
- : Lungpacer Medical
- : Lungpacer Medical Appoints Steven Pfanstiel as Chief Financial Officer
- : Lungpacer Medical
- : Lungpacer Medical
- : Lungpacer Medical Launches AeroPace® System to Enhance Weaning from Mechanical Ventilation
- : Lungpacer Medical
- : Lungpacer Medical, Inc.
- : Lungpacer Medical, Inc.
- : Lungpacer Medical, Inc.
Lungpacer Medical funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2026 | Venture | $7.8M |
| Apr 2026 | Venture | $16.0M |
| Apr 2025 | Venture | $10.0M |
| Apr 2022 | Venture | $20.0M |
| Jan 2021 | Venture | $16.0M |
Leadership
- Doug Evans, President & CEO
- Douglas Evans, Executive Officer, Director
- Joseph Kaufmann, Director
- Josh Makower, Director
- Jose Gordo, Director
- Bob Donohue, Director
- Christopher Kiple, Director
- Valeska Schroeder, Director
Verified email and direct lines for Lungpacer Medical’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Lungpacer Medical files 5 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Lungpacer Medical in the news
- Lungpacer Medical Announces Presentation of DONATE Data Reporting an Increase in Availability of Donor Lungs - GlobeNewswire (Jun 23, 2026)
- Lungpacer picks up reimbursement win for AeroPace - MassDevice (Jul 22, 2026)
- Lungpacer Medical Nominated for 2026 Prix Galien USA Award for Best Medical Technology - GlobeNewswire (Aug 19, 2026)
- Temple Hospital becomes 'home court' for Exton firm's medical technology - The Business Journals (Jul 27, 2026)
- Lungpacer Announces CMS NTAP Approval for AeroPace® System in FY2026 IPPS Final Rule - Yahoo Finance (Aug 14, 2025)
- Lungpacer Medical Announces Positive Results from STIMULUS Trial: Diaphragm Neurostimulation Improves Hemodynamic Performance During Mechanical Ventilation - Simon Fraser University (Feb 25, 2025)
- Lungpacer Medical Appoints Steven Pfanstiel as Chief Financial Officer - Yahoo Finance (Jun 01, 2026)
- Lungpacer Medical will nearly double workforce to support first product launch - The Business Journals (Mar 20, 2025)
Companies similar to Lungpacer Medical
- Cognito Therapeutics · Healthcare, Health Care
- Cytrellis Biosystems · Healthcare, Health Care
- EnsoData · Healthcare, Health Care
- 410 Medical · Healthcare, Health Care
- Enlaza Therapeutics · Healthcare, Health Care
About Lungpacer Medical: questions and answers
What does Lungpacer Medical do?
Lungpacer Medical, Inc., is a privately held medical device company focused on improving respiratory and critical care medicine. Headquartered in Vancouver, Canada, and with US offices in Exton, Pennsylvania, Lungpacer Medical is dedicated to designing non-surgical, minimally invasive technologies to ventilate patients more safely and effectively.
Where is Lungpacer Medical headquartered?
Lungpacer Medical is headquartered in EXTON, Pennsylvania, United States.
How many employees does Lungpacer Medical have?
Lungpacer Medical has about 58 employees.
Has Lungpacer Medical raised funding?
Yes. Fundz has recorded 5 funding events for Lungpacer Medical. The most recent, $7.8M, was in Oct 2026.
Who leads Lungpacer Medical?
Doug Evans is a President & CEO at Lungpacer Medical.
What is the latest news on Lungpacer Medical?
On Oct 14, 2026, Lungpacer Medical
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy